Cargando…

Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome

AIMS: More than one-third of type 2 long QT syndrome (LQT2) patients carry KCNH2 non-missense variants that can result in haploinsufficiency (HI), leading to mechanistic loss-of-function. However, their clinical phenotypes have not been fully investigated. The remaining two-thirds of patients harbou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aizawa, Takanori, Wada, Yuko, Hasegawa, Kanae, Huang, Hai, Imamura, Tomohiko, Gao, Jingshan, Kashiwa, Asami, Kohjitani, Hirohiko, Fukuyama, Megumi, Kato, Koichi, Kato, Eri Toda, Hisamatsu, Takashi, Ohno, Seiko, Makiyama, Takeru, Kimura, Takeshi, Horie, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105889/ https://www.ncbi.nlm.nih.gov/pubmed/36861347 http://dx.doi.org/10.1093/europace/euac269

Ejemplares similares

Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model
por: Hirose, Sayako, et al.
Publicado: (2020)

Pueraria mirifica, an estrogenic tropical herb, unveiled the severity of Type 1 LQTS caused by KCNQ1‐T587M
por: Kashiwa, Asami, et al.
Publicado: (2021)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020)

Gradient-based parameter optimization method to determine membrane ionic current composition in human induced pluripotent stem cell-derived cardiomyocytes
por: Kohjitani, Hirohiko, et al.
Publicado: (2022)

Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells
por: Yoshinaga, Daisuke, et al.
Publicado: (2019)

Acquired Long-QT Syndrome: Mild but Abnormal?
por: Kashiwa, Asami, et al.
Publicado: (2017)

Increased Ca(V)1.2 late current by a CACNA1C p.R412M variant causes an atypical Timothy syndrome without syndactyly
por: Ozawa, Junichi, et al.
Publicado: (2022)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients
por: Takaki, Tadashi, et al.
Publicado: (2019)

Erratum to “Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients”
por: Takaki, Tadashi, et al.
Publicado: (2020)

Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2
por: Sawyer, Briana L., et al.
Publicado: (2020)

A hERG mutation E1039X produced a synergistic lesion on I(Ks) together with KCNQ1-R174C mutation in a LQTS family with three compound mutations
por: Wu, Jie, et al.
Publicado: (2018)

Computerized misinterpretation of QT interval in 12‐lead electrocardiogram and its clinical consequences: A case of recurrent syncope
por: Hasegawa, Kanae, et al.
Publicado: (2023)

Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation()
por: Aoki, Hisaaki, et al.
Publicado: (2017)

Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation
por: Mihic, Anton, et al.
Publicado: (2011)

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene
por: Giustetto, Carla, et al.
Publicado: (2015)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort
por: Kerr, Shona M., et al.
Publicado: (2019)

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report
por: Caiffa, Thomas, et al.
Publicado: (2022)

Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1
por: Shimamoto, Keiko, et al.
Publicado: (2022)

Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol
por: Zhang, Shugang, et al.
Publicado: (2022)

Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing
por: Fazelifar, Amir Farjam, et al.
Publicado: (2023)

KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences
por: Ke, ZunPing, et al.
Publicado: (2023)

Targeted deep sequencing analyses of long QT syndrome in a Japanese population
por: Nagata, Yuki, et al.
Publicado: (2022)

Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator
por: Kojima, Katsumi, et al.
Publicado: (2022)

Novel KCNH1 Mutations Associated with Epilepsy: Broadening the Phenotypic Spectrum of KCNH1-Associated Diseases
por: von Wrede, Randi, et al.
Publicado: (2021)

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2
por: Christiansen, Michael, et al.
Publicado: (2014)

A Novel KCNH2 S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
por: Cheng, Yu-Wen, et al.
Publicado: (2023)

Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia
por: Sasaki, Kenichi, et al.
Publicado: (2016)

Long QT syndrome in chromosome 7q35q36.3 deletion involving KCNH2 gene: Warning for chlorpheniramine prescription
por: Di Stolfo, Giuseppe, et al.
Publicado: (2019)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early‐onset long QT syndrome and sinoatrial node dysfunction
por: Yang, Zhe, et al.
Publicado: (2021)

KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort
por: Lorca, Rebeca, et al.
Publicado: (2022)

Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes
por: Kekenes-Huskey, Peter M., et al.
Publicado: (2022)

A case of long QT syndrome type 2 that developed torsades de pointes two days after the initiation of oral β-blocker therapy
por: Yoneda, Fumiya, et al.
Publicado: (2022)

A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG
por: Turker, Isik, et al.
Publicado: (2016)

Application of Multigene Panel Sequencing in Patients with Prolonged Rate-corrected QT Interval and No Pathogenic Variants Detected in KCNQ1, KCNH2, and SCN5A
por: Seo, Soo Hyun, et al.
Publicado: (2018)

Structure of the C-terminal Region of a KCNH Channel
por: Brelidze, Tinatin I., et al.
Publicado: (2012)

The structural mechanism of KCNH-channel regulation by the eag domain
por: Haitin, Yoni, et al.
Publicado: (2013)

Is KCNH1 mutation related to coronary artery ectasia
por: Noori, Mohammad Rafi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8u5sii3ug5s5mvtsvpi3hhe376